메뉴 건너뛰기
Osteoporosis International
Volumn 22, Issue 4, 2011, Pages 1023-1036
Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
Author keywords

Ankylosing spondylitis; Biologic therapies; Bone loss; Inflammatory joint diseases; Osteoporosis; Rheumatoid arthritis; TNF blockers; Tocilizumab
Indexed keywords

ABATACEPT; ADALIMUMAB; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;
EID: 79953306817     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1462-4     Document Type: Review
Times cited : (38)
References (128)
  • 3
    • 79953321907 scopus 로고    scopus 로고
    • Primer on the metabolic bone diseases and disorders of mineral metabolism (5th Ed)
    • Goldring SR (2003) Primer on the metabolic bone diseases and disorders of mineral metabolism (5th Ed). American Society of Bone and Mineral Research
    • (2003) American Society of Bone and Mineral Research
    • Goldring, S.R.1
  • 5
    • 0031817901 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset
    • FM McQueen N Stewart J Crabbe E Robinson S Yeoman PL Tan L McLean 1998 Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset Ann Rheum Dis 57 350 356 9771209 1:STN:280:DyaK1cvksVWnug%3D%3D (Pubitemid 28378310)
    • (1998) Annals of the Rheumatic Diseases , vol.57 , Issue.6 , pp. 350-356
    • McQueen, F.M.1    Stewart, N.2    Crabbe, J.3    Robinson, E.4    Yeoman, S.5    Tan, P.L.J.6    McLean, L.7
  • 6
    • 0041571736 scopus 로고    scopus 로고
    • New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier
    • DOI 10.1002/art.11076
    • M Ostergaard M Hansen M Stoltenberg KE Jensen M Szkudlarek B Pedersen-Zbinden I Lorenzen 2003 New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier Arthritis Rheum 48 2128 2131 12905465 (Pubitemid 36959192)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.8 , pp. 2128-2131
    • Ostergaard, M.1    Hansen, M.2    Stoltenberg, M.3    Jensen, K.E.4    Szkudlarek, M.5    Pedersen-Zbinden, B.6    Lorenzen, I.7
  • 7
    • 0032933102 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement
    • FM McQueen N Stewart J Crabbe E Robinson S Yeoman PL Tan L McLean 1999 Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement Ann Rheum Dis 58 156 163 10364913 1:STN:280:DyaK1M3ptlantQ%3D%3D (Pubitemid 29172571)
    • (1999) Annals of the Rheumatic Diseases , vol.58 , Issue.3 , pp. 156-163
    • McQueen, F.M.1    Stewart, N.2    Crabbe, J.3    Robinson, E.4    Yeoman, S.5    Tan, P.L.J.6    McLean, L.7
  • 9
    • 45349090842 scopus 로고    scopus 로고
    • Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: Bone marrow oedema predicts erosive progression
    • DOI 10.1136/ard.2007.071977
    • EA Haavardsholm P Boyesen M Ostergaard A Schildvold TK Kvien 2008 Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow edema predicts erosive progression Ann Rheum Dis 67 794 800 17981915 1:STN:280:DC%2BD1czgvFSqtw%3D%3D (Pubitemid 351843277)
    • (2008) Annals of the Rheumatic Diseases , vol.67 , Issue.6 , pp. 794-800
    • Haavardsholm, E.A.1    Boyesen, P.2    Ostergaard, M.3    Schildvold, A.4    Kvien, T.K.5
  • 11
    • 0034884188 scopus 로고    scopus 로고
    • What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease
    • FM McQueen N Benton J Crabbe E Robinson S Yeoman L McLean N Stewart 2001 What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease Ann Rheum Dis 60 859 868 11502613 1:STN:280:DC%2BD3Mvls1Ojug%3D%3D (Pubitemid 32778176)
    • (2001) Annals of the Rheumatic Diseases , vol.60 , Issue.9 , pp. 859-868
    • McQueen, F.M.1    Benton, N.2    Crabbe, J.3    Robinson, E.4    Yeoman, S.5    McLean, L.6    Stewart, N.7
  • 12
    • 0034541599 scopus 로고    scopus 로고
    • The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: A comparison with conventional radiography
    • DOI 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#
    • RJ Wakefield WW Gibbon PG Conaghan P O'Connor D McGonagle C Pease MJ Green DJ Veale JD Isaacs P Emery 2000 The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography Arthritis Rheum 43 2762 2770 11145034 1:STN:280:DC%2BD3M%2FnvFymug%3D%3D (Pubitemid 32001742)
    • (2000) Arthritis and Rheumatism , vol.43 , Issue.12 , pp. 2762-2770
    • Wakefield, R.J.1    Gibbon, W.W.2    Conaghan, P.G.3    O'Connor, P.4    McGonagle, D.5    Pease, C.6    Green, M.J.7    Veale, D.J.8    Isaacs, J.D.9    Emery, P.10
  • 13
    • 0035157664 scopus 로고    scopus 로고
    • Magnetic resonance imaging and miniarthroscopy of metacarpophalangeal joints: Sensitive detection of morphologic changes in rheumatoid arthritis
    • DOI 10.1002/1529-0131(200111)44:11<2492::AID-ART429>3.0.CO;2-X
    • B Ostendorf R Peters P Dann A Becker A Scherer F Wedekind J Friemann KP Schulitz U Modder M Schneider 2001 Magnetic resonance imaging and miniarthroscopy of metacarpophalangeal joints: sensitive detection of morphologic changes in rheumatoid arthritis Arthritis Rheum 44 2492 2502 11710705 1:STN:280:DC%2BD3MnmsFekug%3D%3D (Pubitemid 33049327)
    • (2001) Arthritis and Rheumatism , vol.44 , Issue.11 , pp. 2492-2502
    • Ostendorf, B.1    Peters, R.2    Dann, P.3    Becker, A.4    Scherer, A.5    Wedekind, F.6    Friemann, J.7    Schulitz, K.-P.8    Modder, U.9    Schneider, M.10
  • 14
    • 0028037511 scopus 로고
    • Measurement of hand bone mineral content by dual energy x-ray absorptiometry: Development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis
    • AA Deodhar J Brabyn PW Jones MJ Davis AD Woolf 1994 Measurement of hand bone mineral content by dual energy x-ray absorptiometry: development of the method, and its application in normal volunteers and in patients with rheumatoid arthritis Ann Rheum Dis 53 685 690 7979583 1:STN:280:DyaK2M%2FntVemug%3D%3D (Pubitemid 24330605)
    • (1994) Annals of the Rheumatic Diseases , vol.53 , Issue.10 , pp. 685-690
    • Deodhar, A.A.1    Brabyn, J.2    Jones, P.W.3    Davis, M.J.4    Woolf, A.D.5
  • 15
    • 0028285469 scopus 로고
    • Bone mineral density of the hand in rheumatoid arthritis
    • DOI 10.1002/art.1780370702
    • NF Peel AJ Spittlehouse DE Bax R Eastell 1994 Bone mineral density of the hand in rheumatoid arthritis Arthritis Rheum 37 983 991 8024625 1:STN:280:DyaK2c3ps1CltA%3D%3D (Pubitemid 24222088)
    • (1994) Arthritis and Rheumatism , vol.37 , Issue.7 , pp. 983-991
    • Peel, N.F.A.1    Spittlehouse, A.J.2    Bax, D.E.3    Eastell, R.4
  • 17
    • 0030469471 scopus 로고    scopus 로고
    • Clinical associations of dual-energy X-ray absorptiometry measurement of hand bone mass in rheumatoid arthritis
    • 9010053 1:STN:280:DyaK2s7mtlaiug%3D%3D
    • J Devlin J Lilley A Gough A Huissoon R Holder R Reece P Perkins P Emery 1996 Clinical associations of dual-energy X-ray absorptiometry measurement of hand bone mass in rheumatoid arthritis Br J Rheumatol 35 1256 1262 9010053 1:STN:280:DyaK2s7mtlaiug%3D%3D
    • (1996) Br J Rheumatol , vol.35 , pp. 1256-1262
    • Devlin, J.1    Lilley, J.2    Gough, A.3    Huissoon, A.4    Holder, R.5    Reece, R.6    Perkins, P.7    Emery, P.8
  • 19
    • 0033923757 scopus 로고    scopus 로고
    • Detailed analyses of periarticular osteoporosis in rheumatoid arthritis
    • DOI 10.1007/s001980070106
    • FE Alenfeld E Diessel M Brezger J Sieper D Felsenberg J Braun 2000 Detailed analyses of periarticular osteoporosis in rheumatoid arthritis Osteoporos Int 11 400 407 10912841 1:STN:280:DC%2BD3cvgvFelug%3D%3D (Pubitemid 30450122)
    • (2000) Osteoporosis International , vol.11 , Issue.5 , pp. 400-407
    • Alenfeld, F.E.1    Diessel, E.2    Brezger, M.3    Sieper, J.4    Felsenberg, D.5    Braun, J.6
  • 20
    • 77952668877 scopus 로고    scopus 로고
    • A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis
    • 20381399
    • A Fouque-Aubert R Chapurlat P Miossec PD Delmas 2010 A comparative review of the different techniques to assess hand bone damage in rheumatoid arthritis Joint Bone Spine 77 212 217 20381399
    • (2010) Joint Bone Spine , vol.77 , pp. 212-217
    • Fouque-Aubert, A.1    Chapurlat, R.2    Miossec, P.3    Delmas, P.D.4
  • 22
    • 0028305241 scopus 로고
    • Generalised bone loss in patients with early rheumatoid arthritis
    • DOI 10.1016/S0140-6736(94)91049-9
    • AK Gough J Lilley S Eyre RL Holder P Emery 1994 Generalised bone loss in patients with early rheumatoid arthritis Lancet 344 23 27 7912297 1:STN:280:DyaK2c3osFGruw%3D%3D (Pubitemid 24199420)
    • (1994) Lancet , vol.344 , Issue.8914 , pp. 23-27
    • Gough, A.K.S.1    Lilley, J.2    Eyre, S.3    Holder, R.L.4    Emery, P.5
  • 23
    • 0028147482 scopus 로고
    • Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis
    • AK Gough NF Peel R Eastell RL Holder J Lilley P Emery 1994 Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis Ann Rheum Dis 53 14 17 8311548 1:STN:280:DyaK2c7ksFWkuw%3D%3D (Pubitemid 24067402)
    • (1994) Annals of the Rheumatic Diseases , vol.53 , Issue.1 , pp. 14-17
    • Gough, A.K.S.1    Peel, N.F.A.2    Eastell, R.3    Holder, R.L.4    Lilley, J.5    Emery, P.6
  • 24
    • 0041767274 scopus 로고    scopus 로고
    • Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis
    • DOI 10.1007/s00223-002-1024-7
    • J Iwamoto T Takeda S Ichimura 2003 Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis Calcif Tissue Int 72 491 497 12574873 1:CAS:528:DC%2BD3sXjt1aktrw%3D (Pubitemid 36919515)
    • (2003) Calcified Tissue International , vol.72 , Issue.4 , pp. 491-497
    • Iwamoto, J.1    Takeda, T.2    Ichimura, S.3
  • 25
    • 0033120581 scopus 로고    scopus 로고
    • Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: Assessment with serum type I collagen breakdown products
    • DOI 10.1016/S8756-3282(98)00193-8, PII S8756328298001938
    • P Garnero P Jouvenne N Buchs PD Delmas P Miossec 1999 Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products Bone 24 381 385 10221550 1:STN:280:DyaK1M3js1Oguw%3D%3D (Pubitemid 29134976)
    • (1999) Bone , vol.24 , Issue.4 , pp. 381-385
    • Garnero, P.1    Jouvenne, P.2    Buchs, N.3    Delmas, P.D.4    Miossec, P.5
  • 26
    • 77956050875 scopus 로고    scopus 로고
    • Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis
    • 20525836
    • LH van Tuyl AE Voskuyl M Boers P Geusens RB Landewe BA Dijkmans WF Lems 2010 Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis Ann Rheum Dis 69 9 1623 1628 20525836
    • (2010) Ann Rheum Dis , vol.69 , Issue.9 , pp. 1623-1628
    • Van Tuyl, L.H.1    Voskuyl, A.E.2    Boers, M.3    Geusens, P.4    Landewe, R.B.5    Dijkmans, B.A.6    Lems, W.F.7
  • 27
    • 0035661739 scopus 로고    scopus 로고
    • Osteoporosis screening in systemic lupus erythematosus: Impact of disease duration and organ damage
    • A Becker R Fischer WA Scherbaum M Schneider 2001 Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage Lupus 10 809 814 11789491 1:STN:280:DC%2BD38%2FmtlOmsA%3D%3D (Pubitemid 34007895)
    • (2001) Lupus , vol.10 , Issue.11 , pp. 809-814
    • Becker, A.1    Fischer, R.2    Scherbaum, W.A.3    Schneider, M.4
  • 28
    • 0027507822 scopus 로고
    • Loss of trabecular bone mineral density in systemic lupus erythematosus
    • DOI 10.1002/art.1780361212
    • AA Kalla AB Fataar SJ Jessop L Bewerunge 1993 Loss of trabecular bone mineral density in systemic lupus erythematosus Arthritis Rheum 36 1726 1734 8250992 1:STN:280:DyaK2c%2Fnt1ShsA%3D%3D (Pubitemid 23360013)
    • (1993) Arthritis and Rheumatism , vol.36 , Issue.12 , pp. 1726-1734
    • Kalla, A.A.1    Fataar, A.B.2    Jessop, S.J.3    Bewerunge, L.4
  • 30
    • 27744495914 scopus 로고    scopus 로고
    • Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease
    • 16128948 1:CAS:528:DC%2BD2MXhtFWmsL%2FL
    • M Bernstein S Irwin GR Greenberg 2005 Maintenance infliximab treatment is associated with improved bone mineral density in Crohn's disease Am J Gastroenterol 100 2031 2035 16128948 1:CAS:528:DC%2BD2MXhtFWmsL%2FL
    • (2005) Am J Gastroenterol , vol.100 , pp. 2031-2035
    • Bernstein, M.1    Irwin, S.2    Greenberg, G.R.3
  • 31
    • 0033504715 scopus 로고    scopus 로고
    • Significant loss of bone mass in patients with early, active ankylosing spondylitis: A followup study
    • DOI 10.1002/1529-0131(199911)42:11<2319::AID-ANR9>3.0.CO;2-G
    • J Gratacos A Collado F Pons M Osaba R Sanmarti M Roque M Larrosa J Munoz-Gomez 1999 Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study Arthritis Rheum 42 2319 2324 10555026 1:STN:280:DC%2BD3c%2FitFCqtQ%3D%3D (Pubitemid 30333411)
    • (1999) Arthritis and Rheumatism , vol.42 , Issue.11 , pp. 2319-2324
    • Gratacos, J.1    Collado, A.2    Pons, F.3    Osaba, M.4    Sanmarti, R.5    Roque, M.6    Larrosa, M.7    Munoz-Gomez, J.8
  • 32
    • 0034894002 scopus 로고    scopus 로고
    • Changes in bone density in patients with ankylosing spondylitis: A two-year follow-up study
    • DOI 10.1007/s001980170084
    • JF Maillefert LS Aho A El Maghraoui M Dougados C Roux 2001 Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study Osteoporos Int 12 605 609 11527060 1:STN:280:DC%2BD3MvosFanuw%3D%3D (Pubitemid 32777439)
    • (2001) Osteoporosis International , vol.12 , Issue.7 , pp. 605-609
    • Maillefert, J.F.1    Aho, L.S.2    El Maghraoui, A.3    Dougados, M.4    Roux, C.5
  • 33
    • 0024810864 scopus 로고
    • Osteoporosis in early ankylosing spondylitis: A primary pathological event?
    • R Will R Palmer AK Bhalla F Ring A Calin 1989 Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2 1483 1485 2574769 1:STN:280:DyaK3c%2FpslersA%3D%3D (Pubitemid 20018143)
    • (1989) Lancet , vol.2 , Issue.8678-8679 , pp. 1483-1485
    • Will, R.1    Palmer, R.2    Bhalla, A.K.3    Ring, F.4    Calin, A.5
  • 34
    • 0036606093 scopus 로고    scopus 로고
    • Osteoporosis III: Diagnosis of osteoporosis and assessment of fracture risk
    • DOI 10.1016/S0140-6736(02)08761-5
    • JA Kanis 2002 Diagnosis of osteoporosis and assessment of fracture risk Lancet 359 1929 1936 12057569 (Pubitemid 34615775)
    • (2002) Lancet , vol.359 , Issue.9321 , pp. 1929-1936
    • Kanis, J.A.1
  • 35
    • 43049175471 scopus 로고    scopus 로고
    • FRAX and the assessment of fracture probability in men and women from the UK
    • 18292978 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D
    • JA Kanis O Johnell A Oden H Johansson E McCloskey 2008 FRAX and the assessment of fracture probability in men and women from the UK Osteoporos Int 19 385 397 18292978 1:STN:280:DC%2BD1c7nvF2ntA%3D%3D
    • (2008) Osteoporos Int , vol.19 , pp. 385-397
    • Kanis, J.A.1    Johnell, O.2    Oden, A.3    Johansson, H.4    McCloskey, E.5
  • 38
    • 0022648104 scopus 로고
    • Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors
    • DOI 10.1038/319516a0
    • DR Bertolini GE Nedwin TS Bringman DD Smith GR Mundy 1986 Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors Nature 319 516 518 3511389 1:CAS:528:DyaL28XhtVOlu70%3D (Pubitemid 16212936)
    • (1986) Nature , vol.319 , Issue.6053 , pp. 516-518
    • Bertoli, D.R.1    Nedwin, G.E.2    Bringman, T.S.3
  • 39
    • 0027467377 scopus 로고
    • The effect of natural and surgical menopause on the secretion of cytokines from human blood monocytes
    • R Pacifici LV Avioli 1993 The effect of natural and surgical menopause on the secretion of cytokines from human blood monocytes Osteoporos Int 3 Suppl 1 106 107 8461533 (Pubitemid 23099904)
    • (1993) Osteoporosis International , vol.3 , Issue.SUPPL. 1 , pp. 106-107
    • Pacifici, R.1    Avioli, L.V.2
  • 40
    • 0030950131 scopus 로고    scopus 로고
    • Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency
    • P Ammann R Rizzoli JP Bonjour S Bourrin JM Meyer P Vassalli I Garcia 1997 Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency J Clin Invest 99 1699 1703 9120014 1:CAS:528:DyaK2sXitlanur8%3D (Pubitemid 27163821)
    • (1997) Journal of Clinical Investigation , vol.99 , Issue.7 , pp. 1699-1703
    • Ammann, P.1    Rizzoli, R.2    Bonjour, J.-P.3    Bourrin, S.4    Meyer, J.-M.5    Vassalli, P.6    Garcia, I.7
  • 42
    • 0030678549 scopus 로고    scopus 로고
    • Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
    • P Ducy R Zhang V Geoffroy AL Ridall G Karsenty 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation Cell 89 747 754 9182762 1:CAS:528:DyaK2sXjs1ejsbg%3D (Pubitemid 27516177)
    • (1997) Cell , vol.89 , Issue.5 , pp. 747-754
    • Ducy, P.1    Zhang, R.2    Geoffroy, V.3    Ridall, A.L.4    Karsenty, G.5
  • 43
    • 0036306768 scopus 로고    scopus 로고
    • Transcription factors in bone: Developmental and pathological aspects
    • DOI 10.1016/S1471-4914(02)02340-7, PII S1471491402023407
    • X Yang G Karsenty 2002 Transcription factors in bone: developmental and pathological aspects Trends Mol Med 8 340 345 12114114 1:CAS:528: DC%2BD38XltFagt78%3D (Pubitemid 34733388)
    • (2002) Trends in Molecular Medicine , vol.8 , Issue.7 , pp. 340-345
    • Yang, X.1    Karsenty, G.2
  • 46
  • 47
    • 1642526641 scopus 로고    scopus 로고
    • hi Osteoclast Precursors but Is Essential for Mature Osteoclast Formation in TNFα-Mediated Inflammatory Arthritis
    • DOI 10.1359/JBMR.0301233
    • P Li EM Schwarz RJ O'Keefe L Ma BF Boyce L Xing 2004 RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis J Bone Miner Res 19 207 213 14969390 1:CAS:528: DC%2BD2cXhs1emu7s%3D (Pubitemid 38116734)
    • (2004) Journal of Bone and Mineral Research , vol.19 , Issue.2 , pp. 207-213
    • Li, P.1    Schwarz, E.M.2    O'Keefe, R.J.3    Ma, L.4    Boyce, B.F.5    Xing, L.6
  • 51
    • 69349093225 scopus 로고    scopus 로고
    • Interleukin-17 and type 17 helper T cells
    • P Miossec T Korn VK Kuchroo 2010 Interleukin-17 and type 17 helper T cells N Engl J Med 361 888 898
    • (2010) N Engl J Med , vol.361 , pp. 888-898
    • Miossec, P.1    Korn, T.2    Kuchroo, V.K.3
  • 53
    • 0035048597 scopus 로고    scopus 로고
    • IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis
    • DOI 10.1186/ar294
    • M Chabaud E Lubberts L Joosten W van Den Berg P Miossec 2001 IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis Arthritis Res 3 168 177 11299057 1:STN:280: DC%2BD3M3htVyhtQ%3D%3D (Pubitemid 32303433)
    • (2001) Arthritis Research , vol.3 , Issue.3 , pp. 168-177
    • Chabaud, M.1    Lubberts, E.2    Joosten, L.3    Van Den Berg, W.4    Miossec, P.5
  • 54
    • 33646349199 scopus 로고    scopus 로고
    • Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort)
    • DOI 10.1002/art.21749
    • BW Kirkham MN Lassere JP Edmonds KM Juhasz PA Bird CS Lee R Shnier IJ Portek 2006 Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort) Arthritis Rheum 54 1122 1131 16572447 1:CAS:528: DC%2BD28XksVyht7c%3D (Pubitemid 43672925)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.4 , pp. 1122-1131
    • Kirkham, B.W.1    Lassere, M.N.2    Edmonds, J.P.3    Juhasz, K.M.4    Bird, P.A.5    Lee, C.S.6    Shnier, R.7    Portek, I.J.8
  • 59
    • 0033708837 scopus 로고    scopus 로고
    • Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha
    • 11086024 1:CAS:528:DC%2BD3cXotlChu78%3D
    • S Cenci MN Weitzmann C Roggia N Namba D Novack J Woodring R Pacifici 2000 Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha J Clin Invest 106 1229 1237 11086024 1:CAS:528:DC%2BD3cXotlChu78%3D
    • (2000) J Clin Invest , vol.106 , pp. 1229-1237
    • Cenci, S.1    Weitzmann, M.N.2    Roggia, C.3    Namba, N.4    Novack, D.5    Woodring, J.6    Pacifici, R.7
  • 60
    • 43949139580 scopus 로고    scopus 로고
    • Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
    • DOI 10.1002/art.23417
    • SB Cohen RK Dore NE Lane PA Ory CG Peterfy JT Sharp D van der Heijde L Zhou W Tsuji R Newmark 2008 Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial Arthritis Rheum 58 1299 1309 18438830 1:CAS:528:DC%2BD1cXms1ehu70%3D (Pubitemid 351705919)
    • (2008) Arthritis and Rheumatism , vol.58 , Issue.5 , pp. 1299-1309
    • Cohen, S.B.1    Dore, R.K.2    Lane, N.E.3    Ory, P.A.4    Peterfy, C.G.5    Sharp, J.T.6    Van Der Heijde, D.7    Zhou, L.8    Tsuji, W.9    Newmark, R.10
  • 61
    • 8444236292 scopus 로고    scopus 로고
    • TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis
    • DOI 10.1016/j.bone.2004.07.004, PII S8756328204002996
    • N Saidenberg-Kermanac'h A Corrado D Lemeiter MC deVernejoul MC Boissier ME Cohen-Solal 2004 TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis Bone 35 1200 1207 15542046 (Pubitemid 39487367)
    • (2004) Bone , vol.35 , Issue.5 , pp. 1200-1207
    • Saidenberg-Kermanac'H, N.1    Corrado, A.2    Lemeiter, D.3    Devernejoul, M.C.4    Boissier, M.C.5    Cohen-Solal, M.E.6
  • 63
    • 33749150667 scopus 로고    scopus 로고
    • Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
    • DOI 10.1136/ard.2005.044198
    • M Vis EA Havaardsholm G Haugeberg T Uhlig AE Voskuyl RJ van de Stadt BA Dijkmans AD Woolf TK Kvien WF Lems 2006 Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis Ann Rheum Dis 65 1495 1499 16606653 1:CAS:528:DC%2BD28Xht1OjtL3E (Pubitemid 44629129)
    • (2006) Annals of the Rheumatic Diseases , vol.65 , Issue.11 , pp. 1495-1499
    • Vis, M.1    Havaardsholm, E.A.2    Haugeberg, G.3    Uhlig, T.4    Voskuyl, A.E.5    Van De Stadt, R.J.6    Dijkmans, B.A.C.7    Woolf, A.D.8    Kvien, T.K.9    Lems, W.F.10
  • 64
    • 28544447762 scopus 로고    scopus 로고
    • Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody: A prospective open-label pilot study
    • DOI 10.1093/rheumatology/kei082
    • U Lange J Teichmann U Muller-Ladner J Strunk 2005 Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study Rheumatol (Oxf) 44 1546 1548 1:CAS:528:DC%2BD2MXht1GltrzI (Pubitemid 41742473)
    • (2005) Rheumatology , vol.44 , Issue.12 , pp. 1546-1548
    • Lange, U.1    Teichmann, J.2    Muller-Ladner, U.3    Strunk, J.4
  • 65
    • 33745593028 scopus 로고    scopus 로고
    • Bone metabolism changes during anti-TNF-α therapy in patients with active rheumatoid arthritis
    • DOI 10.1196/annals.1351.040
    • B Seriolo S Paolino A Sulli V Ferretti M Cutolo 2006 Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis Ann NY Acad Sci 1069 420 427 16855169 1:CAS:528:DC%2BD28XovF2gt7o%3D (Pubitemid 43989885)
    • (2006) Annals of the New York Academy of Sciences , vol.1069 , pp. 420-427
    • Seriolo, B.1    Paolino, S.2    Sulli, A.3    Ferretti, V.4    Cutolo, M.5
  • 66
    • 34548443592 scopus 로고    scopus 로고
    • A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
    • 17597527
    • H Marotte B Pallot-Prades L Grange P Gaudin C Alexandre P Miossec 2007 A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab Arthritis Res Ther 9 R61 17597527
    • (2007) Arthritis Res Ther , vol.9 , pp. 61
    • Marotte, H.1    Pallot-Prades, B.2    Grange, L.3    Gaudin, P.4    Alexandre, C.5    Miossec, P.6
  • 68
    • 61449164945 scopus 로고    scopus 로고
    • Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: Arrest of bone loss
    • 18408246 1:CAS:528:DC%2BD1MXjs1WitLg%3D
    • CA Wijbrandts R Klaasen MG Dijkgraaf DM Gerlag BL van Eck-Smit PP Tak 2009 Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss Ann Rheum Dis 68 373 376 18408246 1:CAS:528:DC%2BD1MXjs1WitLg%3D
    • (2009) Ann Rheum Dis , vol.68 , pp. 373-376
    • Wijbrandts, C.A.1    Klaasen, R.2    Dijkgraaf, M.G.3    Gerlag, D.M.4    Van Eck-Smit, B.L.5    Tak, P.P.6
  • 69
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • DOI 10.1002/art.21519
    • FC Breedveld MH Weisman AF Kavanaugh SB Cohen K Pavelka R van Vollenhoven J Sharp JL Perez GT Spencer-Green 2006 The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 26 37 16385520 1:CAS:528:DC%2BD28XhsVens74%3D (Pubitemid 43122183)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.1 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    Van Vollenhoven, R.6    Sharp, J.7    Perez, J.L.8    Spencer-Green, G.T.9
  • 70
    • 67549150896 scopus 로고    scopus 로고
    • Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: Explorative analyses from the PREMIER study
    • 18801760 1:CAS:528:DC%2BD1MXovVCmsrY%3D
    • M Hoff TK Kvien J Kalvesten A Elden G Haugeberg 2009 Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study Ann Rheum Dis 68 1171 1176 18801760 1:CAS:528: DC%2BD1MXovVCmsrY%3D
    • (2009) Ann Rheum Dis , vol.68 , pp. 1171-1176
    • Hoff, M.1    Kvien, T.K.2    Kalvesten, J.3    Elden, A.4    Haugeberg, G.5
  • 73
    • 0034094123 scopus 로고    scopus 로고
    • Successful treatment of active ankylosing spondylitis with the anti- tumor necrosis factor α monoclonal antibody infliximab
    • DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E
    • J Brandt H Haibel D Cornely W Golder J Gonzalez J Reddig W Thriene J Sieper J Braun 2000 Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab Arthritis Rheum 43 1346 1352 10857793 1:CAS:528:DC%2BD3cXkvFWnu70%3D (Pubitemid 30416320)
    • (2000) Arthritis and Rheumatism , vol.43 , Issue.6 , pp. 1346-1352
    • Brandt, J.1    Haibel, H.2    Cornely, D.3    Golder, W.4    Gonzalez, J.5    Reddig, J.6    Thriene, W.7    Sieper, J.8    Braun, J.9
  • 74
    • 0037379299 scopus 로고    scopus 로고
    • Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
    • DOI 10.1136/ard.62.4.347
    • F Allali M Breban R Porcher JF Maillefert M Dougados C Roux 2003 Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha Ann Rheum Dis 62 347 349 12634235 1:CAS:528:DC%2BD3sXjtVKksbs%3D (Pubitemid 36363442)
    • (2003) Annals of the Rheumatic Diseases , vol.62 , Issue.4 , pp. 347-349
    • Allali, F.1    Breban, M.2    Porcher, R.3    Maillefert, J.F.4    Dougados, M.5    Roux, C.6
  • 75
    • 22244433242 scopus 로고    scopus 로고
    • Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
    • DOI 10.1136/ard.2004.028670
    • K Briot P Garnero A Le Henanff M Dougados C Roux 2005 Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor alpha treatment Ann Rheum Dis 64 1137 1140 15642695 1:CAS:528:DC%2BD2MXpslGmsro%3D (Pubitemid 41113346)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.8 , pp. 1137-1140
    • Briot, K.1    Garnero, P.2    Le Henanff, A.3    Dougados, M.4    Roux, C.5
  • 76
    • 44349177615 scopus 로고    scopus 로고
    • Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-α treatment
    • K Briot L Gossec S Kolta M Dougados C Roux 2008 Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment J Rheumatol 35 855 861 18381782 1:CAS:528:DC%2BD1cXntVOmurg%3D (Pubitemid 351747128)
    • (2008) Journal of Rheumatology , vol.35 , Issue.5 , pp. 855-861
    • Briot, K.1    Gossec, L.2    Kolta, S.3    Dougados, M.4    Roux, C.5
  • 77
    • 58849156499 scopus 로고    scopus 로고
    • Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
    • 18495735 1:CAS:528:DC%2BD1MXisVSjs7w%3D
    • S Visvanathan D van der Heijde A Deodhar C Wagner DG Baker J Han J Braun 2009 Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis Ann Rheum Dis 68 175 182 18495735 1:CAS:528:DC%2BD1MXisVSjs7w%3D
    • (2009) Ann Rheum Dis , vol.68 , pp. 175-182
    • Visvanathan, S.1    Van Der Heijde, D.2    Deodhar, A.3    Wagner, C.4    Baker, D.G.5    Han, J.6    Braun, J.7
  • 79
    • 20444478272 scopus 로고    scopus 로고
    • Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis
    • DOI 10.1172/JCI23738
    • RJ Lories I Derese FP Luyten 2005 Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis J Clin Invest 115 1571 1579 15902307 1:CAS:528:DC%2BD2MXkvF2mu7c%3D (Pubitemid 40814665)
    • (2005) Journal of Clinical Investigation , vol.115 , Issue.6 , pp. 1571-1579
    • Lories, R.J.U.1    Derese, I.2    Luyten, F.P.3
  • 80
    • 67349104400 scopus 로고    scopus 로고
    • Interleukin-6 as a key player in systemic inflammation and joint destruction
    • 19189867 1:CAS:528:DC%2BD1MXovFaqs70%3D
    • JE Fonseca MJ Santos H Canhao E Choy 2009 Interleukin-6 as a key player in systemic inflammation and joint destruction Autoimmun Rev 8 538 542 19189867 1:CAS:528:DC%2BD1MXovFaqs70%3D
    • (2009) Autoimmun Rev , vol.8 , pp. 538-542
    • Fonseca, J.E.1    Santos, M.J.2    Canhao, H.3    Choy, E.4
  • 81
    • 33750474405 scopus 로고    scopus 로고
    • Interleukin 6: From bench to bedside
    • DOI 10.1038/ncprheum0338, PII NCPRHEUM0338
    • N Nishimoto T Kishimoto 2006 Interleukin 6: from bench to bedside Nat Clin Pract Rheumatol 2 619 626 17075601 1:CAS:528:DC%2BD28Xht1emtLnI (Pubitemid 44650950)
    • (2006) Nature Clinical Practice Rheumatology , vol.2 , Issue.11 , pp. 619-626
    • Nishimoto, N.1    Kishimoto, T.2
  • 83
    • 0033863433 scopus 로고    scopus 로고
    • Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis
    • 10765930 1:CAS:528:DC%2BD3cXivFOitrY%3D
    • H Yamanaka Y Matsuda M Tanaka W Sendo H Nakajima A Taniguchi N Kamatani 2000 Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis Arthritis Rheum 43 852 858 10765930 1:CAS:528: DC%2BD3cXivFOitrY%3D
    • (2000) Arthritis Rheum , vol.43 , pp. 852-858
    • Yamanaka, H.1    Matsuda, Y.2    Tanaka, M.3    Sendo, W.4    Nakajima, H.5    Taniguchi, A.6    Kamatani, N.7
  • 84
    • 35348910957 scopus 로고    scopus 로고
    • Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers
    • DOI 10.1002/art.22923
    • S Young-Min T Cawston N Marshall D Coady S Christgau T Saxne S Robins I Griffiths 2007 Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers Arthritis Rheum 56 3236 3247 17907159 1:CAS:528:DC%2BD2sXht12rtLnO (Pubitemid 47585418)
    • (2007) Arthritis and Rheumatism , vol.56 , Issue.10 , pp. 3236-3247
    • Young-Min, S.1    Cawston, T.2    Marshall, N.3    Coady, D.4    Christgau, S.5    Saxne, T.6    Robins, S.7    Griffiths, I.8
  • 85
    • 0023942493 scopus 로고
    • Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
    • 3260102 1:STN:280:DyaL1c3ltFGisA%3D%3D
    • FA Houssiau JP Devogelaer J Van Damme CN de Deuxchaisnes J Van Snick 1988 Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides Arthritis Rheum 31 784 788 3260102 1:STN:280:DyaL1c3ltFGisA%3D%3D
    • (1988) Arthritis Rheum , vol.31 , pp. 784-788
    • Houssiau, F.A.1    Devogelaer, J.P.2    Van Damme, J.3    De Deuxchaisnes, C.N.4    Van Snick, J.5
  • 86
    • 0027518860 scopus 로고
    • Serum interleukin 6 levels in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity
    • R Madhok A Crilly J Watson HA Capell 1993 Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity Ann Rheum Dis 52 232 234 8484679 1:STN:280:DyaK3s3kvFejtw%3D%3D (Pubitemid 23094315)
    • (1993) Annals of the Rheumatic Diseases , vol.52 , Issue.3 , pp. 232-234
    • Madhok, R.1    Crilly, A.2    Watson, J.3    Capell, H.A.4
  • 87
    • 0027305079 scopus 로고
    • Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis
    • U Sack RW Kinne T Marx P Heppt S Bender F Emmrich 1993 Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis Rheumatol Int 13 45 51 8356390 1:STN:280:DyaK3szmtF2jsg%3D%3D (Pubitemid 23247813)
    • (1993) Rheumatology International , vol.13 , Issue.2 , pp. 45-51
    • Sack, U.1    Kinne, R.W.2    Marx, T.3    Heppt, P.4    Bender, S.5    Emmrich, F.6
  • 89
    • 52149099504 scopus 로고    scopus 로고
    • IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: Results from a 24-week multicentre randomized placebo-controlled trial
    • 18625622 1:CAS:528:DC%2BD1cXhtl2gsbbI
    • P Emery E Keystone HP Tony A Cantagrel R van Vollenhoven A Sanchez E Alecock J Lee J Kremer 2008 IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomized placebo-controlled trial Ann Rheum Dis 67 1516 1523 18625622 1:CAS:528:DC%2BD1cXhtl2gsbbI
    • (2008) Ann Rheum Dis , vol.67 , pp. 1516-1523
    • Emery, P.1    Keystone, E.2    Tony, H.P.3    Cantagrel, A.4    Van Vollenhoven, R.5    Sanchez, A.6    Alecock, E.7    Lee, J.8    Kremer, J.9
  • 90
    • 54949150604 scopus 로고    scopus 로고
    • Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
    • 18821691 1:CAS:528:DC%2BD1cXht12rur%2FJ
    • MC Genovese JD McKay EL Nasonov EF Mysler NA da Silva E Alecock T Woodworth JJ Gomez-Reino 2008 Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study Arthritis Rheum 58 2968 2980 18821691 1:CAS:528:DC%2BD1cXht12rur%2FJ
    • (2008) Arthritis Rheum , vol.58 , pp. 2968-2980
    • Genovese, M.C.1    McKay, J.D.2    Nasonov, E.L.3    Mysler, E.F.4    Da Silva, N.A.5    Alecock, E.6    Woodworth, T.7    Gomez-Reino, J.J.8
  • 91
    • 33749363027 scopus 로고    scopus 로고
    • Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate
    • DOI 10.1002/art.22033
    • RN Maini PC Taylor J Szechinski K Pavelka J Broll G Balint P Emery F Raemen J Petersen J Smolen D Thomson T Kishimoto 2006 Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate Arthritis Rheum 54 2817 2829 16947782 1:CAS:528: DC%2BD28XhtFWksLjK (Pubitemid 44497760)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.9 , pp. 2817-2829
    • Maini, R.N.1    Taylor, P.C.2    Szechinski, J.3    Pavelka, K.4    Broll, J.5    Balint, G.6    Emery, P.7    Raemen, F.8    Petersen, J.9    Smolen, J.10    Thomson, D.11    Kishimoto, T.12
  • 92
    • 2642558925 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial
    • DOI 10.1002/art.20303
    • N Nishimoto K Yoshizaki N Miyasaka K Yamamoto S Kawai T Takeuchi J Hashimoto J Azuma T Kishimoto 2004 Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial Arthritis Rheum 50 1761 1769 15188351 1:CAS:528:DC%2BD2cXlsFaqtL4%3D (Pubitemid 38725087)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.6 , pp. 1761-1769
    • Nishimoto, N.1    Yoshizaki, K.2    Miyasaka, N.3    Yamamoto, K.4    Kawai, S.5    Takeuchi, T.6    Hashimoto, J.7    Azuma, J.8    Kishimoto, T.9
  • 93
    • 40749114497 scopus 로고    scopus 로고
    • Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): A double-blind, placebo-controlled, randomised trial
    • DOI 10.1016/S0140-6736(08)60453-5, PII S0140673608604535
    • JS Smolen A Beaulieu A Rubbert-Roth C Ramos-Remus J Rovensky E Alecock T Woodworth R Alten 2008 Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomized trial Lancet 371 987 997 18358926 1:CAS:528:DC%2BD1cXjs1Sltbc%3D (Pubitemid 351392039)
    • (2008) The Lancet , vol.371 , Issue.9617 , pp. 987-997
    • Smolen, J.S.1    Beaulieu, A.2    Rubbert-Roth, A.3    Ramos-Remus, C.4    Rovensky, J.5    Alecock, E.6    Woodworth, T.7    Alten, R.8
  • 94
    • 34447300492 scopus 로고    scopus 로고
    • Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
    • DOI 10.1136/ard.2006.068064
    • N Nishimoto J Hashimoto N Miyasaka K Yamamoto S Kawai T Takeuchi N Murata D van der Heijde T Kishimoto 2007 Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab Ann Rheum Dis 66 1162 1167 17485422 1:CAS:528:DC%2BD2sXhtVKltL7O (Pubitemid 47309731)
    • (2007) Annals of the Rheumatic Diseases , vol.66 , Issue.9 , pp. 1162-1167
    • Nishimoto, N.1    Hashimoto, J.2    Miyasaka, N.3    Yamamoto, K.4    Kawai, S.5    Takeuchi, T.6    Murata, N.7    Van Heijde, D.D.8    Kishimoto, T.9
  • 95
    • 74849102659 scopus 로고    scopus 로고
    • Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
    • 20039425 1:CAS:528:DC%2BC3cXhtFGnurnI
    • P Garnero E Thompson T Woodworth JS Smolen 2010 Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone Arthritis Rheum 62 33 43 20039425 1:CAS:528:DC%2BC3cXhtFGnurnI
    • (2010) Arthritis Rheum , vol.62 , pp. 33-43
    • Garnero, P.1    Thompson, E.2    Woodworth, T.3    Smolen, J.S.4
  • 96
    • 69249205598 scopus 로고    scopus 로고
    • A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms
    • 19376193 1:CAS:528:DC%2BD1MXhtVKlsr%2FK
    • CB Confavreux RL Levine G Karsenty 2009 A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms Mol Cell Endocrinol 310 21 29 19376193 1:CAS:528:DC%2BD1MXhtVKlsr%2FK
    • (2009) Mol Cell Endocrinol , vol.310 , pp. 21-29
    • Confavreux, C.B.1    Levine, R.L.2    Karsenty, G.3
  • 97
    • 77955035304 scopus 로고    scopus 로고
    • Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
    • 20655470 1:CAS:528:DC%2BC3cXpsVahsr4%3D
    • M Ferron J Wei T Yoshizawa A Del Fattore RA DePinho A Teti P Ducy G Karsenty 2010 Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism Cell 142 296 308 20655470 1:CAS:528:DC%2BC3cXpsVahsr4%3D
    • (2010) Cell , vol.142 , pp. 296-308
    • Ferron, M.1    Wei, J.2    Yoshizawa, T.3    Del Fattore, A.4    Depinho, R.A.5    Teti, A.6    Ducy, P.7    Karsenty, G.8
  • 99
    • 7044277863 scopus 로고    scopus 로고
    • The role of interleukin-1 in bone resorption in rheumatoid arthritis
    • V Strand AF Kavanaugh 2004 The role of interleukin-1 in bone resorption in rheumatoid arthritis Rheumatology (Oxford) 43 Suppl 3 iii10 ii16
    • (2004) Rheumatology (Oxford) , vol.43 , Issue.SUPPL. 3
    • Strand, V.1    Kavanaugh, A.F.2
  • 100
    • 0029670029 scopus 로고    scopus 로고
    • Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells
    • 8617720 1:CAS:528:DyaK28XhtlOnsbw%3D
    • E Jimi T Ikebe N Takahashi M Hirata T Suda T Koga 1996 Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells J Biol Chem 271 4605 4608 8617720 1:CAS:528:DyaK28XhtlOnsbw%3D
    • (1996) J Biol Chem , vol.271 , pp. 4605-4608
    • Jimi, E.1    Ikebe, T.2    Takahashi, N.3    Hirata, M.4    Suda, T.5    Koga, T.6
  • 101
    • 0032588998 scopus 로고    scopus 로고
    • Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
    • DOI 10.1016/S8756-3282(99)00162-3, PII S8756328299001623
    • LC Hofbauer DL Lacey CR Dunstan TC Spelsberg BL Riggs S Khosla 1999 Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells Bone 25 255 259 10495128 1:CAS:528:DyaK1MXls1Wiu78%3D (Pubitemid 29406050)
    • (1999) Bone , vol.25 , Issue.3 , pp. 255-259
    • Hofbauer, L.C.1    Lacey, D.L.2    Dunstan, C.R.3    Spelsberg, T.C.4    Riggs, B.L.5    Khosla, S.6
  • 102
    • 0025288396 scopus 로고
    • Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist
    • WP Arend HG Welgus RC Thompson SP Eisenberg 1990 Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist J Clin Invest 85 1694 1697 2139669 1:CAS:528:DyaK3cXktlylsL0%3D (Pubitemid 20176469)
    • (1990) Journal of Clinical Investigation , vol.85 , Issue.5 , pp. 1694-1697
    • Arend, W.P.1    Welgus, H.G.2    Thompson, R.C.3    Eisenberg, S.P.4
  • 103
    • 0024271034 scopus 로고
    • Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit
    • B Henderson FM Rowe CR Bird AJ Gearing 1988 Production of interleukin 1 in the joint during the development of antigen-induced arthritis in the rabbit Clin Exp Immunol 74 371 376 3266117 1:CAS:528:DyaL1MXptlaqug%3D%3D (Pubitemid 19039725)
    • (1988) Clinical and Experimental Immunology , vol.74 , Issue.3 , pp. 371-376
    • Henderson, B.1    Rowe, F.M.2    Bird, C.R.3    Gearing, A.J.H.4
  • 104
    • 0022606130 scopus 로고
    • Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid
    • P Miossec CA Dinarello M Ziff 1986 Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid Arthritis Rheum 29 461 470 3486662 1:CAS:528:DyaL28Xit1egsro%3D (Pubitemid 16118694)
    • (1986) Arthritis and Rheumatism , vol.29 , Issue.4 , pp. 461-470
    • Miossec, P.1    Dinarello, C.A.2    Ziff, M.3
  • 105
    • 0023694150 scopus 로고
    • Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis
    • 2901567 1:STN:280:DyaL1czjsVSmsw%3D%3D
    • JA Eastgate JA Symons NC Wood FM Grinlinton FS di Giovine GW Duff 1988 Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis Lancet 2 706 709 2901567 1:STN:280:DyaL1czjsVSmsw%3D%3D
    • (1988) Lancet , vol.2 , pp. 706-709
    • Eastgate, J.A.1    Symons, J.A.2    Wood, N.C.3    Grinlinton, F.M.4    Di Giovine, F.S.5    Duff, G.W.6
  • 106
    • 0026684213 scopus 로고
    • Determination of cytokines in synovial fluids: Correlation with diagnosis and histomorphological characteristics of synovial tissue
    • 1616355 1:STN:280:DyaK38zhtlSquw%3D%3D
    • P Kahle JG Saal K Schaudt J Zacher P Fritz G Pawelec 1992 Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue Ann Rheum Dis 51 731 734 1616355 1:STN:280:DyaK38zhtlSquw%3D%3D
    • (1992) Ann Rheum Dis , vol.51 , pp. 731-734
    • Kahle, P.1    Saal, J.G.2    Schaudt, K.3    Zacher, J.4    Fritz, P.5    Pawelec, G.6
  • 108
    • 0036190776 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial
    • DOI 10.1002/art.10141
    • S Cohen E Hurd J Cush M Schiff ME Weinblatt LW Moreland J Kremer MB Bear WJ Rich D McCabe 2002 Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial Arthritis Rheum 46 614 624 11920396 1:CAS:528:DC%2BD38XisFOmt7w%3D (Pubitemid 34214243)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.3 , pp. 614-624
    • Cohen, S.1    Hurd, E.2    Cush, J.3    Schiff, M.4    Weinblatt, M.E.5    Moreland, L.W.6    Kremer, J.7    Bear, M.B.8    Rich, W.J.9    McCabe, D.10
  • 109
    • 0034083128 scopus 로고    scopus 로고
    • A multicenter, double-blind, dose-ranging, randomized, placebo- controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scores
    • DOI 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P
    • Y Jiang HK Genant I Watt M Cobby B Bresnihan R Aitchison D McCabe 2000 A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores Arthritis Rheum 43 1001 1009 10817552 1:CAS:528:DC%2BD3cXjvVeitbg%3D (Pubitemid 30368176)
    • (2000) Arthritis and Rheumatism , vol.43 , Issue.5 , pp. 1001-1009
    • Jiang, Y.1    Genant, H.K.2    Watt, I.3    Cobby, M.4    Bresnihan, B.5    Aitchison, R.6    McCabe, D.7
  • 110
    • 0037236618 scopus 로고    scopus 로고
    • Radiographic data from recent randomized controlled trials in rheumatoid arthritis: What have we learned?
    • DOI 10.1002/art.10683
    • V Strand JT Sharp 2003 Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? Arthritis Rheum 48 21 34 12528100 (Pubitemid 36091644)
    • (2003) Arthritis and Rheumatism , vol.48 , Issue.1 , pp. 21-34
    • Strand, V.1    Sharp, J.T.2
  • 111
    • 0033915371 scopus 로고    scopus 로고
    • Cytokines and bone loss in a 5-year longitudinal study hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: The Danish Osteoporosis Prevention Study
    • B Abrahamsen V Bonnevie-Nielsen EN Ebbesen J Gram H Beck-Nielsen 2000 Cytokines and bone loss in a 5-year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study J Bone Miner Res 15 1545 1554 10934653 1:CAS:528:DC%2BD3cXlvVSjt7s%3D (Pubitemid 30484524)
    • (2000) Journal of Bone and Mineral Research , vol.15 , Issue.8 , pp. 1545-1554
    • Abrahamsen, B.1    Bonnevie-Nielsen, V.2    Ebbesen, E.N.3    Gram, J.4    Beck-Nielsen, H.5
  • 112
    • 0036725838 scopus 로고    scopus 로고
    • Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women
    • 1:CAS:528:DC%2BD38XnslCqsr0%3D
    • R Fontova C Gutierrez J Vendrell M Broch I Vendrell I Simon JM Fernandez-Real C Richart 2002 Bone mineral mass is associated with interleukin 1 receptor autoantigen and TNF-alpha gene polymorphisms in post-menopausal Mediterranean women J Endocrinol Investig 25 684 690 1:CAS:528: DC%2BD38XnslCqsr0%3D
    • (2002) J Endocrinol Investig , vol.25 , pp. 684-690
    • Fontova, R.1    Gutierrez, C.2    Vendrell, J.3    Broch, M.4    Vendrell, I.5    Simon, I.6    Fernandez-Real, J.M.7    Richart, C.8
  • 113
    • 0032189033 scopus 로고    scopus 로고
    • Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
    • DOI 10.1016/S8756-3282(98)00109-4, PII S8756328298001094
    • RW Keen KL Woodford-Richens JS Lanchbury TD Spector 1998 Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine Bone 23 367 371 9763149 1:CAS:528:DyaK1cXmsFeit7c%3D (Pubitemid 28454629)
    • (1998) Bone , vol.23 , Issue.4 , pp. 367-371
    • Keen, R.W.1    Woodford-Richens, K.L.2    Lanchbury, J.S.3    Spector, T.D.4
  • 114
    • 0034006946 scopus 로고    scopus 로고
    • Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1β gene
    • BL Langdahl E Lokke M Carstens LL Stenkjaer EF Eriksen 2000 Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene J Bone Miner Res 15 402 414 10750554 1:CAS:528: DC%2BD3cXitFaksbc%3D (Pubitemid 30134084)
    • (2000) Journal of Bone and Mineral Research , vol.15 , Issue.3 , pp. 402-414
    • Langdahl, B.L.1    Lokke, E.2    Carstens, M.3    Stenkjaer, L.L.4    Eriksen, E.F.5
  • 115
    • 0033800141 scopus 로고    scopus 로고
    • Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women
    • 11033452 1:CAS:528:DC%2BD3cXnt1Sjt70%3D
    • E Bajnok I Takacs P Vargha G Speer Z Nagy P Lakatos 2000 Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women Bone 27 559 562 11033452 1:CAS:528:DC%2BD3cXnt1Sjt70%3D
    • (2000) Bone , vol.27 , pp. 559-562
    • Bajnok, E.1    Takacs, I.2    Vargha, P.3    Speer, G.4    Nagy, Z.5    Lakatos, P.6
  • 116
    • 1842848028 scopus 로고    scopus 로고
    • Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women
    • DOI 10.1016/S8756-3282(02)00873-6, PII S8756328202008736
    • KO Han JT Choi IG Moon MS Jeong CH Yim HY Chung HC Jang HK Yoon IK Han 2002 Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women Bone 31 612 615 12477576 1:CAS:528:DC%2BD38XptlGisrg%3D (Pubitemid 35449704)
    • (2002) Bone , vol.31 , Issue.5 , pp. 612-615
    • Han, K.O.1    Choi, J.T.2    Moon, I.G.3    Jeong, M.S.4    Yim, C.H.5    Chung, H.Y.6    Jang, H.C.7    Yoon, H.K.8    Han, I.K.9
  • 117
    • 29244464297 scopus 로고    scopus 로고
    • Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women
    • DOI 10.1007/s00774-005-0646-z
    • JG Kim KS Lim SY Ku SH Kim YM Choi SY Moon 2006 Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women J Bone Miner Metab 24 53 57 16369899 1:CAS:528:DC%2BD2MXhtlCqt7nL (Pubitemid 41821504)
    • (2006) Journal of Bone and Mineral Metabolism , vol.24 , Issue.1 , pp. 53-57
    • Kim, J.G.1    Lim, K.S.2    Ku, S.-Y.3    Kim, S.H.4    Choi, Y.M.5    Moon, S.Y.6
  • 119
    • 34447303828 scopus 로고    scopus 로고
    • Effect of blockade of TNF-α and interleukin-1 action on bone resorption in early postmenopausal women
    • DOI 10.1359/jbmr.070207
    • N Charatcharoenwitthaya S Khosla EJ Atkinson LK McCready BL Riggs 2007 Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women J Bone Miner Res 22 724 729 17295604 1:CAS:528:DC%2BD2sXpt1yrt7c%3D (Pubitemid 351339101)
    • (2007) Journal of Bone and Mineral Research , vol.22 , Issue.5 , pp. 724-729
    • Charatcharoenwitthaya, N.1    Khosla, S.2    Atkinson, E.J.3    McCready, L.K.4    Riggs, B.L.5
  • 122
    • 0036275436 scopus 로고    scopus 로고
    • Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion
    • DOI 10.1002/art.10294
    • LW Moreland R Alten F Van den Bosch T Appelboom M Leon P Emery S Cohen M Luggen W Shergy I Nuamah JC Becker 2002 Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion Arthritis Rheum 46 1470 1479 12115176 1:CAS:528:DC%2BD38Xltlanurs%3D (Pubitemid 34620192)
    • (2002) Arthritis and Rheumatism , vol.46 , Issue.6 , pp. 1470-1479
    • Moreland, L.W.1    Alten, R.2    Van Den Bosch, F.3    Appelboom, T.4    Leon, M.5    Emery, P.6    Cohen, S.7    Luggen, M.8    Shergy, W.9    Nuamah, I.10    Becker, J.-C.11
  • 123
    • 27844440810 scopus 로고    scopus 로고
    • Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis
    • DOI 10.1016/j.jaut.2005.09.020, PII S0896841105001289
    • C Kliwinski D Kukral J Postelnek B Krishnan L Killar A Lewin S Nadler R Townsend 2005 Prophylactic administration of abatacept prevents disease and bone destruction in a rat model of collagen-induced arthritis J Autoimmun 25 165 171 16256307 1:CAS:528:DC%2BD2MXht1Ghs7vP (Pubitemid 41654460)
    • (2005) Journal of Autoimmunity , vol.25 , Issue.3 , pp. 165-171
    • Kliwinski, C.1    Kukral, D.2    Postelnek, J.3    Krishnan, B.4    Killar, L.5    Lewin, A.6    Nadler, S.7    Townsend, R.8
  • 128
    • 77950663905 scopus 로고    scopus 로고
    • Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss
    • 20392239 1:CAS:528:DC%2BC3cXmsVSrtrs%3D
    • B Bedi JY Li F Grassi H Tawfeek MN Weitzmann R Pacifici 2010 Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss Ann NY Acad Sci 1192 215 221 20392239 1:CAS:528:DC%2BC3cXmsVSrtrs%3D
    • (2010) Ann NY Acad Sci , vol.1192 , pp. 215-221
    • Bedi, B.1    Li, J.Y.2    Grassi, F.3    Tawfeek, H.4    Weitzmann, M.N.5    Pacifici, R.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.